GSK 650394
Tocris Bioscience, part of Bio-Techne | Catalog # 3572
Serum- and glucocorticoid-regulated kinase (SGK) inhibitor
Key Product Details
Description
Serum- and glucocorticoid-regulated kinase (SGK) inhibitor
Product Description
GSK 650394 is a serum- and glucocorticoid-regulated kinase 1 (SGK1) inhibitor (IC50 values are 62 and 103 nM for SGK1 and SGK2 respectively). Displays >30-fold selectivity over Akt and other related kinases. Inhibits androgen-stimulated growth of LNCaP cells, a human prostate carcinoma cell line (IC50 ~ 1 μM).Licensing Information
Sold with the permission of GlaxoSmithKlineProduct Specifications
Molecular Weight
382.45
Formula
C25H22N2O2
Storage
Store at RT
Purity
≥97% (HPLC)
Chemical Name
2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoic acid
CAS Number
890842-28-1
PubChem ID
25022668
InChI Key
WVSBGSNVCDAMCF-UHFFFAOYSA-N
SMILES
O=C(C(C(C5CCCC5)=C4)=CC=C4C2=CNC1=NC=C(C3=CC=CC=C3)C=C12)O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 38.24 | 100 |
Preparing Stock Solutions
for GSK 650394
The following data is based on the product molecular weight 382.45
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.61 mL | 13.07 mL | 26.15 mL |
| 5 mM | 0.52 mL | 2.61 mL | 5.23 mL |
| 10 mM | 0.26 mL | 1.31 mL | 2.61 mL |
| 50 mM | 0.05 mL | 0.26 mL | 0.52 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Hall Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression. Breast Cancer Res.Treat 2012 PMID: 22842983
- Sherk Development of a small-molecule serum- and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic. Cancer Res. 2008 PMID: 18794135
Product Specific Notices for GSK 650394
For research use only
Loading...
Loading...
Loading...